Jane Street’s Immunocore IMCR Stock Holding History

Jane Street’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10M	Buy	+332,700	New	+$10.8M	﹤0.01%	2532
2025 Q4	–	Sell	-13,700	Closed	-$498K	–	11724
2025 Q3	$498K	Sell	13,700 -49,000	-78%	-$1.66M	﹤0.01%	7876
2025 Q2	$1.97M	Buy	+62,700	New	+$1.95M	﹤0.01%	4441
2024 Q4	–	Sell	-152,200	Closed	-$4.74M	–	9958
2024 Q3	$4.74M	Buy	+152,200	New	+$5.54M	﹤0.01%	2950
2024 Q2	–	Sell	-28,700	Closed	-$1.87M	–	9755
2024 Q1	$1.87M	Buy	+28,700	New	+$1.97M	﹤0.01%	4255
2023 Q1	–	Sell	-29,700	Closed	-$1.69M	–	9434
2022 Q4	$1.69M	Sell	29,700 -30,900	-51%	-$1.74M	﹤0.01%	4105
2022 Q3	$2.85M	Buy	60,600 +2,700	+5%	+$129K	﹤0.01%	3551
2022 Q2	$2.16M	Buy	+57,900	New	+$1.88M	﹤0.01%	4022

Other funds holding IMCR

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Jane Street's IMCR Position: Q1 2026 in Review

Jane Street increased its Immunocore (IMCR) stake by 102% in Q1 2026, buying an estimated $3.35M and bringing the position to 204,368 shares worth $6.16M. The position accounts for ﹤0.01% of the portfolio, ranked #3207.

Jane Street first reported a position in IMCR in Q2 2022 and has held it in 14 quarters since. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

Jane Street held 204,368 shares of Immunocore worth $6.16M as of Q1 2026.
Jane Street bought 103,428 Immunocore shares in Q1 2026, an estimated $3.35M.
Immunocore made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3207 holding.
Jane Street first reported a position in Immunocore in Q2 2022 and has held it in 14 quarters since.
142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.